The MIT spinout will use the financing, from investors and the European Investment Bank, to accelerate the U.S. launch of its Coaptium sutureless nerve repair technology.
The MIT spinout will use the financing, from investors and the European Investment Bank, to accelerate the U.S. launch of its Coaptium sutureless nerve repair technology.